| Literature DB >> 26758264 |
Christoffer C Jørgensen1, Morten Aa Petersen2, Henrik Kehlet1.
Abstract
OBJECTIVES: Construction of a simple preoperative risk score for patients in high risk of potentially preventable 'medical' complications. Secondary objectives were to construct simple preoperative risk scores for 'severe medical', 'surgical' and 'total' potentially preventable complications.Entities:
Mesh:
Year: 2016 PMID: 26758264 PMCID: PMC4716218 DOI: 10.1136/bmjopen-2015-009813
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Included and excluded types of complications
| ‘Medical’ | ‘Surgical’ |
|---|---|
| Included a priori as potentially preventable if resulting in LOS ≥4 or 30 days readmission*:
Myocardial infarction Unstable angina Heart failure Cardiac arrhythmia (LOS >4 days or after discharge but ≥7 days after surgery) Cerebral stroke/transient cerebral ischaemia Delirium/psychosis Venous thromboembolic events Pneumonia/acute worsening of chronic obstructive disease Sepsis without wound infection Unexplained infection Falls Renal infection with increase in creatinine and fluid/diuretic treatment only Fluid/electrolyte derangement treated with fluids only Renal infection resulting in dialysis Mobilisation issues preventing fulfilling functional discharge criteria within 4 days or need of inhospital rehabilitation after discharge Opioid-related side effects | Included a priori as potentially preventable if resulting in LOS >4 or 30 days readmission:
Hip dislocation not caused by falling Knee manipulation under anaesthesia Wound infections with antibiotic treatment Superficial infection with wound incision Deep infection with removal of prosthetic components |
| Included for further evaluation on preventability:
Unexplained hypotension/hypertension Unexplained fainting or dizziness Unexplained dyspnoea Constipation unrelated to opioids Complications related to existing comorbidity† Any condition not fitting other descriptions | Included for further evaluation on preventability: |
| Excluded a priori as being potentially preventable by perioperative intervention:
No recorded morbidity (LOS >4 days only) Postoperative ileus Diarrhoea Disproved venous thromboembolic event Disproved myocardial infarction Disproved wound infection Social considerations | Excluded a priori as being potentially preventable by perioperative intervention:
Postanaesthetic complications Periprosthetic fracture without recorded trauma Revision due to prosthetic malfunction Other planned reoperations Systemic arterial thrombosis/pseudoaneurism |
| Excluded a priori due to lack of information necessary for qualified evaluation:
Gastric ulcer/gastritis Urinary retention Uncomplicated urinary tract infection Pain | Excluded a priori due to lack of information necessary for qualified evaluation:
Major postoperative haematoma/swelling Major intraoperative bleeding Minor wound bleeding |
*Anaemia requiring blood transfusion despite no recorded major intraoperative bleed.
†For example, difficulties with vitamin K or antihyperglycaemic treatment, management of sleep apnoea.
LOS, length of stay.
Preoperative characteristics
| THA | 4565 (52.2) |
| TKA | 4172 (47.8) |
| Age/years median (IQR) | 68 (67–75) |
| <50 | 524 (6.0) |
| 51–60 | 1465 (16.8) |
| 61–65 | 1384 (15.8) |
| 66–70 | 1717 (19.7) |
| 71–75 | 1546 (17,7) |
| 76–80 | 1191 (13.6) |
| 81–85 | 650 (7.4) |
| >85 | 260 (3.0) |
| Females | 5031 (57.8) |
| BMI median (IQR) | 27.7 (24.8–31.2) |
| <18.5 | 69 (0.8) |
| 18.5–24.9 | 2284 (26.2) |
| 25.0–29.9 | 3475 (39.9) |
| 30–34.9 | 1960 (22.5) |
| 35–39.9 | 685 (7.9) |
| >40 | 237 (2.7) |
| Missing | 27 (0.3) |
| BMI ≥30 | 2882 (33.0) |
| Missing | 27 (0.3) |
| Anaemia | 1107 (12.8) |
| Missing | 77 (0.9) |
| Walking aids | 2126 (24.8) |
| Missing | 177 (2.0) |
| Living alone | 2954 (33.8) |
| With others | 5783 (66.2) |
| Missing | 0 (0.0) |
| Smoking | 1325 (15.3) |
| Missing | 90 (1.0) |
| Alcohol >24 g/day | 599 (6.9) |
| Missing | 73 (0.8) |
| Hypertension | 4585 (52.8) |
| Missing | 55 (0.6) |
| Hypercholesterolaemia | 2572 (29.4) |
| Missing | 80 (0.9) |
| Diabetes with antihyperglycaemic treatment | 861 (9.9) |
| Missing | 35 (0.4) |
| Anticoagulant treatment* | 445 (5.1) |
| Missing | 0 (0.0) |
| Cardiac disease | 1083 (12.4) |
| Missing | 128 (1.5) |
| Pulmonary disease | 658 (7.6) |
| Missing | 73 (0.8) |
| PsD with pharmacological treatment | 975 (11.2) |
| Missing | 393 (4.5) |
| Previous stroke | 528 (6.1) |
| Missing | 129 (1.5) |
| Previous venous thromboembolic event | 469 (5.5) |
| Missing | 152 (1.7) |
Parentheses are per cent unless otherwise specified.
*Vitamin K antagonists or new oral anticoagulants.
BMI, body mass index; PsD, psychiatric disorder; THA, total hip arthroplasty; TKA, total knee arthroplasty.
Predictive ability of combinations of significant predictors
| Outcome | Characteristic (%) | Events (%) | Percentage of events | Percentage correct | Sensitivity | Specificity | PPV | NPV | NNT 50 | NNT 33 | NNT 25 | AE 50 | AE 33 | AE 25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes | No | ||||||||||||||
| ‘Medical’ complications n: 327 | Age ≥80 years (12.3) | 118 (11.9) | 872 | 36.1 | 86.5 | 36.09 | 88.67 | 0.12 | 0.97 | 17 | 25 | 34 | 59 | 39 | 30 |
| Walking aids (24.2) | 187 (9.6) | 1753 | 57.2 | 76.4 | 57.19 | 77.22 | 0.10 | 0.98 | 21 | 31 | 41 | 94 | 62 | 47 | |
| Hypertension (52.4) | 221 (5.3) | 3982 | 67.6 | 49.0 | 67.58 | 48.25 | 0.05 | 0.97 | 38 | 57 | 76 | 111 | 74 | 55 | |
| Anticoagulants (5.0) | 42 (10.5) | 357 | 12.8 | 92.0 | 12.84 | 95.36 | 0.11 | 0.96 | 19 | 29 | 38 | 21 | 14 | 11 | |
| Anaemia (12.4) | 94 (9.4) | 904 | 28.7 | 85.8 | 28.75 | 88.25 | 0.09 | 0.97 | 21 | 32 | 42 | 47 | 31 | 24 | |
| Psychological disorder (11.6) | 78 (8.4) | 851 | 23.9 | 86.3 | 23.85 | 88.94 | 0.08 | 0.96 | 24 | 36 | 48 | 39 | 26 | 20 | |
| Pulmonary disease (7.4) | 46 (7.7) | 551 | 14.1 | 89.6 | 14.07 | 92.84 | 0.08 | 0.96 | 26 | 39 | 52 | 23 | 15 | 12 | |
| ≥3 predictors (14.3) | 147 (12.9) | 996 | 45.0 | 85.3 | 44.95 | 87.05 | 0.13 | 0.97 | 16 | 23 | 31 | 74 | 49 | 37 | |
| ≥4 predictors (4.3) | 68 (19.8) | 275 | 20.8 | 93.3 | 20.80 | 96.43 | 0.20 | 0.97 | 10 | 15 | 20 | 34 | 23 | 17 | |
| ≥5 predictors (0.9) | 24 (32.4) | 50 | 7.3 | 95.6 | 7.34 | 99.35 | 0.32 | 0.96 | 6 | 9 | 12 | 12 | 8 | 6 | |
| ≥4 MP2 (18.1) | 174 (12.0) | 1276 | 53.2 | 82.2 | 53.21 | 83.42 | 0.12 | 0.98 | 17 | 25 | 33 | 87 | 58 | 44 | |
| ≥5 MP2 (12.8) | 139 (13.6) | 886 | 42.5 | 86.6 | 42.51 | 88.48 | 0.14 | 0.97 | 15 | 22 | 29 | 70 | 46 | 35 | |
| ≥2 MPEH (19.1) | 182 (11.9) | 1348 | 55.7 | 81.4 | 55.66 | 82.50 | 0.12 | 0.98 | 17 | 25 | 34 | 91 | 61 | 46 | |
| ≥3 MPEH2 (5.6) | 83 (18.5) | 366 | 55.7 | 92.4 | 25.38 | 95.14 | 0.18 | 0.97 | 11 | 16 | 22 | 42 | 28 | 21 | |
| ‘Severe medical’ complications n:213 | Age ≥80 years (12.3) | 70 (7.0) | 928 | 36.8 | 87.1 | 36.84 | 88.32 | 0.07 | 0.98 | 29 | 43 | 57 | 35 | 23 | 18 |
| Walking aids (24.2) | 108 (5.5) | 1861 | 56.8 | 76.1 | 56.84 | 76.57 | 0.05 | 0.99 | 36 | 55 | 73 | 54 | 36 | 27 | |
| Anticoagulants (4.9) | 27 (6.7) | 378 | 14.2 | 93.3 | 14.21 | 95.24 | 0.07 | 0.98 | 30 | 45 | 60 | 14 | 9 | 7 | |
| Psychological disorder (11.6) | 48 (5.1) | 895 | 25.3 | 87.2 | 25.26 | 88.73 | 0.05 | 0.98 | 39 | 59 | 79 | 24 | 16 | 12 | |
| Pulmonary disease (7.5) | 31 (5.11) | 577 | 16.3 | 90.9 | 16.32 | 92.73 | 0.05 | 0.98 | 39 | 59 | 78 | 16 | 10 | 8 | |
| ≥2 predictors (14.9) | 92 (7.6) | 1122 | 48.4 | 85.0 | 48.42 | 85.87 | 0.08 | 0.99 | 26 | 40 | 53 | 46 | 31 | 23 | |
| ≥3 predictors (3.1) | 31 (12.4) | 218 | 16.3 | 95.4 | 16.32 | 97.26 | 0.12 | 0.98 | 16 | 24 | 32 | 16 | 10 | 8 | |
| ≥4 predictors (0.3) | 6 (23.1) | 20 | 3.2 | 97.5 | 3.16 | 99.75 | 0.23 | 0.98 | 9 | 13 | 17 | 3 | 2 | 2 | |
| ≥3 MP (14.3) | 83 (7.3) | 1060 | 43.7 | 85.5 | 44.62 | 86.47 | 0.07 | 0.99 | 28 | 41 | 55 | 42 | 28 | 21 | |
| ≥4 MP2 (18.1) | 98 (7.0) | 1352 | 51.6 | 82.1 | 52.69 | 82.74 | 0.07 | 0.99 | 30 | 44 | 59 | 49 | 33 | 25 | |
| ≥2 MPEH (19.1) | 103 (6.7) | 1427 | 54.2 | 81.2 | 55.38 | 81.79 | 0.07 | 0.99 | 30 | 45 | 59 | 52 | 34 | 26 | |
Number of included patients is 8021 for ‘medical’ complications and 8132 for ‘severe medical’ complications due to 8.1% and 6.9% with missing data on relevant predictors.
AE 25, avoided events in the cohort with 25% event reduction; AE 30, avoided events in the cohort with 30% event reduction; AE 50, avoided events in the cohort with 50% event reduction; MP2, ‘medical’ predictors with two points if OR ≥1.9; MPEH, medical predictors excluding hypertension; MPEH2, ‘medical’ predictors excluding hypertension and two points if OR ≥1.9; NNT 25, number needed to treat if there is a 25% event reduction; NNT 30, number needed to treat if there is a 30% event reduction; NNT 50, number needed to treat if there is a 50% event reduction; NPN, negative predictive value; PPV, positive predictive value.
Figure 1Relationship between per cent of complications and percentage of population for combinations of predictors and weightings. MPEH, medical predictors excluding hypertension.
Figure 2Occurrence and fraction of specific types of ‘medical’ complications in patients with <2 ‘medical’ predictors excluding hypertension (MPEH) n: 6491 vs ≥2 MPEH n: 1530. TCI, transient cerebral ischaemia; VTE, venous thromboembolic event.
Figure 3Occurrence and fraction of specific types of ‘severe medical’ complications in patients with <2 ‘medical’ predictors excluding hypertension (MPEH) n: 6491 vs ≥2 MPEH n: 1530. TCI, transient cerebral ischaemia; VTE, venous thromboembolic event.